The CHMP has rejected the marketing application for abaloparatide (Radius Health) subcutaneous injection for postmenopausal women with osteoporosis at increased risk for fracture.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
